search
Back to results

Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer

Primary Purpose

Breast Cancer

Status
Completed
Phase
Phase 3
Locations
Colombia
Study Type
Interventional
Intervention
Thoracic Paravertebral Block
Surgical Wound Infiltration
Sponsored by
Instituto de Cancerología S.A.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Cancer focused on measuring Paravertebral, Single injection, Breast surgery, Analgesia

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  1. Women older than 18 years.
  2. Diagnosis of breast cancer requiring major elective surgery: unilateral mastectomy with or without axillary dissection; with or without axillary sentinel node biopsy; with or without immediate breast reconstruction.
  3. Willingness to participate in the study during the follow-up period.

Exclusion Criteria:

  1. Metastatic breast carcinoma; tumor involvement of contra lateral breast or armpit determined by clinical or paraclinical studies.
  2. Medical History of coagulopathy.
  3. Consumption of anticoagulants.
  4. Contraindication to NSAIDs or opioids.
  5. Allergy to local anesthetics of amide type.
  6. Infection a interventions sites (paravertebral block or area affected breast surgical wound)
  7. Pregnancy and lactation.
  8. BMI>35.
  9. Parkinson's disease, Alzheimer's disease or other diseases that affect the mental or motor sphere.
  10. Double mastectomy or mastectomy history of previous ipsilateral to the current episode.
  11. Preoperative risk classification ASA IV-V.

Sites / Locations

  • Instituto de Cancerología IDC Las Américas

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Thoracic Paravertebral Block

Surgical Wound Infiltration

Arm Description

to identify the thoracic T3, a parallel line 2.5 cm from the spinous process is drawn and in this place the ultrasound sensor is placed. Ultrasonograph image identifies the transverse process, the intercostal cost-transverse ligament, the pleura and lung. We proceed to insert a needle between the two corresponding transverse processes and positions after passing the cost-ligament posterior intercostal and transverse to the parietal pleura. After negative aspiration for blood, 0.5% bupivacaine anesthetic is administered at doses of 1.5 mg/kg slowly. The volume is defined by the anesthesiologist. The injection of anesthetic is displayed, as well as confirmation of the correct location of the needle because the volume injected above pushes the pleura.

before the close of the skin, it proceeds to infiltrate the subcutaneous tissue and skin with 0.5% bupivacaine at doses of 1.5 mg/kg, generating the widest possible dissemination of the bupivacaine in the surgical area.

Outcomes

Primary Outcome Measures

Acute post-surgical pain at rest and motion
Acute pain at rest and in motion at 2, 4, 6, 12 and 24 hours post operative, measured by a visual analog scale (0-100 mm) for the paravertebral block group compared with the surgical wound infiltration group.

Secondary Outcome Measures

Adverse Events
Compare the frequency and severity of adverse events in both groups
Total doses of opioids
Compare the total dose of self-administered opioids analgesics for the first 24 hours
Time to the first dose of opioids
Compare the time to first dose of opioids analgesics in both groups
Post-mastectomy pain syndrome
Compare the frequency of diagnosis of Post-mastectomy pain syndrome (SDP) two months after breast surgery in both groups
Quality of life
Estimate the changes in the quality of life of patients after two months after breast surgery in both groups

Full Information

First Posted
September 14, 2015
Last Updated
December 23, 2016
Sponsor
Instituto de Cancerología S.A.
search

1. Study Identification

Unique Protocol Identification Number
NCT02609321
Brief Title
Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer
Official Title
Efficacy of Thoracic Paravertebral Block vs Local Anesthesia of the Surgical Wound in Reduction of Acute Post-surgical Pain in Patients With Breast Cancer. Controlled Phase III, Randomized, Single-blind, Superiority Clinical Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
December 2016
Overall Recruitment Status
Completed
Study Start Date
November 2015 (undefined)
Primary Completion Date
August 2016 (Actual)
Study Completion Date
December 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Instituto de Cancerología S.A.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Surgical treatment of breast cancer is frequently associated with postoperative pain in the surgical area. Persistent pain after breast cancer management has considerable negative effects on the quality of life of survivors. The aim of this trials is to evaluate the efficacy of thoracic paravertebral block with bupivacine 0.5% in reducing the acute pain postmastectomy compare with surgical wound infiltration with bupivacaine 0.5%.
Detailed Description
Surgical treatment of breast cancer is frequently associated with postoperative pain in the surgical area, restricted movement of the ipsilateral upper limb and increased risk of chronic pain. This usually occurs even though management with analgesics commonly used in the postoperative period. Properly treatment of acute postoperative pain have essential implications: improving the general welfare of patients, can better withstand future medical interventions, facilitating recovery in the short and long term and is believed to have positive impact on survival from cancer. Persistent pain after breast cancer management has considerable negative effects on the quality of life of survivors. Several risks factors have been described in preoperative, intra-operative and postoperative periods of persistent or chronic pain. In the postoperative period the most important risk factor is the severity of acute pain. For this, pain relief is an essential component of care of patients undergoing breast cancer surgery. Current evidence suggests that treatment of acute postoperative pain reduces the risk of persistent or chronic pain syndrome. The surgical wound infiltration with local anesthesia has been used routinely in patients managed at the Cancer Institute and Clinica Las Americas and is described as a safe and accessible procedure for the management of acute postoperative pain. Paravertebral block represents an interesting alternative in the management of perioperative pain, often used for breast surgery, hernia repair and thoracotomy in children and adults. Although complications associated with blocking are uncommon, the implementation of Ultrasound-guided approach has become the standard for performing said method. Such considerations have led us to evaluate whether patients with breast cancer who are undergoing mastectomy, thoracic paravertebral block could be better in relief acute pain in comparison with surgical wound infiltration with local anesthesia. This will be studied by controlled randomized to one of two intervention groups (paravertebral block or local anesthesia with infiltration of the surgical wound) allocation trial. In all patients, general anesthesia and routine postoperative analgesic is used.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
Paravertebral, Single injection, Breast surgery, Analgesia

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Thoracic Paravertebral Block
Arm Type
Experimental
Arm Description
to identify the thoracic T3, a parallel line 2.5 cm from the spinous process is drawn and in this place the ultrasound sensor is placed. Ultrasonograph image identifies the transverse process, the intercostal cost-transverse ligament, the pleura and lung. We proceed to insert a needle between the two corresponding transverse processes and positions after passing the cost-ligament posterior intercostal and transverse to the parietal pleura. After negative aspiration for blood, 0.5% bupivacaine anesthetic is administered at doses of 1.5 mg/kg slowly. The volume is defined by the anesthesiologist. The injection of anesthetic is displayed, as well as confirmation of the correct location of the needle because the volume injected above pushes the pleura.
Arm Title
Surgical Wound Infiltration
Arm Type
Active Comparator
Arm Description
before the close of the skin, it proceeds to infiltrate the subcutaneous tissue and skin with 0.5% bupivacaine at doses of 1.5 mg/kg, generating the widest possible dissemination of the bupivacaine in the surgical area.
Intervention Type
Procedure
Intervention Name(s)
Thoracic Paravertebral Block
Intervention Description
Thoracic paravertebral block at T3 level with bupivacaine 0.5%, dosis 1.5mg/Kg
Intervention Type
Procedure
Intervention Name(s)
Surgical Wound Infiltration
Intervention Description
Surgical wound infiltration on the skin and subcutaneous tissue in surgical area with bipivacaine 0.5%, dosis 1.5mg/kg
Primary Outcome Measure Information:
Title
Acute post-surgical pain at rest and motion
Description
Acute pain at rest and in motion at 2, 4, 6, 12 and 24 hours post operative, measured by a visual analog scale (0-100 mm) for the paravertebral block group compared with the surgical wound infiltration group.
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Adverse Events
Description
Compare the frequency and severity of adverse events in both groups
Time Frame
2 months
Title
Total doses of opioids
Description
Compare the total dose of self-administered opioids analgesics for the first 24 hours
Time Frame
24 hours
Title
Time to the first dose of opioids
Description
Compare the time to first dose of opioids analgesics in both groups
Time Frame
24 hours
Title
Post-mastectomy pain syndrome
Description
Compare the frequency of diagnosis of Post-mastectomy pain syndrome (SDP) two months after breast surgery in both groups
Time Frame
2 months
Title
Quality of life
Description
Estimate the changes in the quality of life of patients after two months after breast surgery in both groups
Time Frame
2 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women older than 18 years. Diagnosis of breast cancer requiring major elective surgery: unilateral mastectomy with or without axillary dissection; with or without axillary sentinel node biopsy; with or without immediate breast reconstruction. Willingness to participate in the study during the follow-up period. Exclusion Criteria: Metastatic breast carcinoma; tumor involvement of contra lateral breast or armpit determined by clinical or paraclinical studies. Medical History of coagulopathy. Consumption of anticoagulants. Contraindication to NSAIDs or opioids. Allergy to local anesthetics of amide type. Infection a interventions sites (paravertebral block or area affected breast surgical wound) Pregnancy and lactation. BMI>35. Parkinson's disease, Alzheimer's disease or other diseases that affect the mental or motor sphere. Double mastectomy or mastectomy history of previous ipsilateral to the current episode. Preoperative risk classification ASA IV-V.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fernando Herazo, MD, MSc
Organizational Affiliation
Instituto de Cancerología IDC Las Américas
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Hector I García, MD, MPH, MSc
Organizational Affiliation
Instituto de Cancerología IDC Las Américas
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jorge A Egurrola, MD
Organizational Affiliation
Instituto de Cancerología IDC Las Américas
Official's Role
Principal Investigator
Facility Information:
Facility Name
Instituto de Cancerología IDC Las Américas
City
Medellín
State/Province
Antioquia
Country
Colombia

12. IPD Sharing Statement

Citations:
PubMed Identifier
15562083
Citation
Kairaluoma PM, Bachmann MS, Korpinen AK, Rosenberg PH, Pere PJ. Single-injection paravertebral block before general anesthesia enhances analgesia after breast cancer surgery with and without associated lymph node biopsy. Anesth Analg. 2004 Dec;99(6):1837-1843. doi: 10.1213/01.ANE.0000136775.15566.87.
Results Reference
result
PubMed Identifier
18292452
Citation
Sidiropoulou T, Buonomo O, Fabbi E, Silvi MB, Kostopanagiotou G, Sabato AF, Dauri M. A prospective comparison of continuous wound infiltration with ropivacaine versus single-injection paravertebral block after modified radical mastectomy. Anesth Analg. 2008 Mar;106(3):997-1001, table of contents. doi: 10.1213/ane.0b013e31816152da.
Results Reference
result

Learn more about this trial

Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer

We'll reach out to this number within 24 hrs